Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017

Latest news articles

Added 1 month ago Drug news

FDA approves Rapivab (peramivir injection) extending its availability for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older.- BioCryst Pharmaceuticals.

BioCryst Pharmaceuticals, Inc. announced that the FDA has approved a supplemental New Drug Application for Rapivab (peramivir injection), an intravenous...

Added 7 months ago Drug news

BinaxNOW Influenza A & B Card 2 diagnostic test and reader get 510(k) clearance from FDA - Alere

Alere announced that its Alere Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings, has...

Added 9 months ago Drug news

FDA approves marketing application for Xpert Xpress Flu and Xpert Xpress Flu/RSV for influenza-Cepheid

Cepheid announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert Xpress Flu...

Search all news articles for Influenza

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.



Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more.

+ 1 more

Airway Disease

Airway Disease

The Airway Disease Learning Zone is an area where you can access the information about VisionAir and see video presentations from the forum. The Inhalation Technology page features a video presentation from the live broadcast presented by key faculty.

Load more

Journal articles

Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals

Rheumatoid arthritis (RA) patients under immunosuppressive therapy are particularly susceptible to infections, mainly of the respiratory tract, thus vaccination may...

Added 3 years ago

A/H5N1 prepandemic influenza vaccine (Vepacel®): a guide to its use.

Vepacel® is a prepandemic influenza vaccine (whole virion, Vero cell-derived, inactivated) containing antigen of H5N1 strain A/Vietnam/1203/2004 and is approved...

Added 4 years ago

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

The influenza A subtype H5N1 virus is a likely causative agent for the next human influenza pandemic. Pandemic influenza vaccine...

Added 5 years ago

Search all journal articles for Influenza


Diabetes care, antivirals for flu and dementia risk: update clinical February 2016

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Influenza